Study using Biocartis’ liquid biopsy BRAF assay shows new option for retreatment of melanoma patients

March 15, 2017 Leave a comment

Biocartis Group NV , an innovative molecular diagnostics company, today announces the publication in the renowned clinical oncology journal The Lancet Oncology of an important study[1] by Prof. Dr. Bart Neyns from the University Hospital in Brussels (Belgium). In this ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Biocartis Group NV

Study using Biocartis’ liquid biopsy BRAF assay shows new option for retreatment of melanoma patients

Researchers find way to treat lung cancer and associated muscle wasting at the same time

Engineered extracellular vesicles can learn from decades of liposome research

Exercise-enriched extracellular vesicles may help maintain aging cartilage

Everest Biolabs Awarded $2.1 Million NIH SBIR Grant to Advance Extracellular Vesicle Biomarker Discovery at Scale with High-Purity, High-Throughput Isolation

An anti-fibrotic drug could be repurposed to control cell communication

Electronic profiling of neuronal extracellular vesicles enables early prediction of Parkinson’s disease